Variability in the effect of muscle relaxants Factors - Anestezjologia i ...

Anestezjologia i Ratownictwo 2009; 3: 42-56
Anestezjologia • Ratownictwo • Nauka • Praktyka / Anaesthesiology • Rescue Medicine • Science • Practice
442. Stirt JA, Stone DJ, Weinberg G, Willson DF, Sternick CS, Sussman MD. Atracurium in a child with myotonic dystrophy. Anesth Analg
1985; 64: 369-70.
443. Boheimer N, Harris JW, Ward S. Neuromuscular blockade in dystrophia mytonica. Anaesthesia 1985; 40: 872-4.
444. White DA, Smyth DG. Continuous infusion of propofol in dystrophia myotonica. Can J Anaesth 1989; 36: 200-3.
445. Jenkins JA, Facer EK. Anesthetic management of a patient with myotonic dystrophy for a Nissen fundoplication and gastrostomy.
Pediatric Anesthesia 2004; 14: 693-6.
446. Watt NA, Scott RP. Mivacurium chloride and myotonic dystrophy. Br J Anaesth 1995; 75: 498-9.
447. Castano J, Pares N. Anaesthesia for major abdominal surgery in a patient with myotonia dystrophica. Br J Anaesth 1987; 59: 1629-31.
448. Wruck G, Tryba M. [Vecuronium in dystrophia myotonica (Curschmann-Steinert)]. Anaesthesist 1989; 38: 255-8.
449. Diefenbach C, Lynch J, Abel M, Buzello W. Vecuronium forcmuscle relaxation in patients with dystrophia myotonica. Anesthesia and
Analgesia 1993; 76: 872-4.
450. Nishi M, Itoh H, Tsubokawa T, Taniguchi T, Yamamoto K. Effective doses of vecuronium in a patient with myotonic dystrophy.
Anaesthesia 2004; 59: 1216-8.
451. Russell SH, Hirsch NP. Anaesthesia and myotonia. Br J Anaesth 1994; 72: 210-6.
452. Wiesel S, BevanJC, Samuel J, Donati F. Vecuronium neuromuscular blockade in a child with mitochondrial myopathy. Anesth Analg
1991; 72: 696-9.
453. Naguib M, El Dawlatly AA, Ashour M, Al-Bunyan M. Sensitivity to mivacurium in a patient with mitochondrial myopathy. Anesthesiology
1996; 84: 1506-9.
454. Finsterer J, Stratil U, Bittner R, Sporn P. Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy. Can J Anaesth
1998; 45: 781-4.
455. Wisely NA, Cook PR. General anaesthesia in a man with mitochondrial myopathy undergoing eye surgery. Eur J Anaesthesiol 2001;
18: 333-5.
456. Klockgether-Radke A, Henze T, Braun U, Kettler D. Anesthesia in two patients with mitochondrial myopathy. Anaesthesist 1993; 42:
111-4.
457. Thompson VA, Wahr JA. Anesthetic considerations in patients presenting with mitochondrial myopathy, encephalopathy, lactic acidosis,
and stroke-like episodes (MELAS) syndrome. Anesth Analg 1997; 85: 1404-6.
458. Ciccotelli KK, Prak EL, Muravchick S. An adult with inherited mitochondrial encephalomyopathy: report of a case. Anesthesiology
1997; 87: 1240-2.
459. Aouad MT, Gerges FJ, Baraka AS. Resistance to cisatracurium in a patient with MELAS syndrome. Paediatr Anaesth 2005; 15:
1124-7.
460. Martyn JAJ, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors: Effects on
neuromuscular blockers. Anesthesiology 1992; 76: 822-43.
461. Gronert GA, Lambert EH, Theye RA. The response of denervated skeletal muscle to succinylcholine. Anesthesiology 1973; 39: 13-22.
462. Hogue CW Jr, Itani MS, Martyn JA. Resistance to d-tubocurarine in lower motor neuron injury is related to increased acetylcholine
receptors at the neuromuscular junction. Anesthesiology 1990; 73: 703-9.
463. Graham DH. Monitoring neuromuscular block may be unreliable in patients with upper motor-neuron lesions. Anesthesiology 1980;
52: 74-5.
464. Moorthy SS, Hilgenberg JC. Resistance to non-depolarizing muscle relaxants in paretic upper extremities of patients with residual
hemiplegia. Anesth Analg 1980; 59: 624-7.
465. Shayevitz JR, Matteo RS. Decreased sensitivity to metocurine in patients with upper motoneuron disease. Anesth Analg 1985; 64:
767-72.
466. Baraka AS, Jalbout MI. Anesthesia and myopathy. Curr Opin Anaesthesiol 2002; 15: 371-6.
467. Hara K, Minami K, Takamato K, Shiraishi M, Sata T. The prolonged effect of a muscle relaxant in a patient with chronic inflammatory
demyelinating polyradiculoneuropathy. Anesth Analg 2000; 90: 224-6.
468. Fink H, Bogdanski R, Luppa P, Martyn JA, Blobner M. Nitric oxide is not a mediator of inflammation-induced resistance to atracurium.
Anesth Analg 2005; 101: 1362-7.
469. Fink H, Luppa P, Mayer B, Rosenbrock H, Metzger J, Martyn JA, Blobner M. Systemic inflammation leads to resistance to atracurium
without increasing membrane expression of acetylcholine receptors. Anesthesiology 2003; 98: 82-8.
470. Blobner M, Kochs E, Fink H, Veihelmann A, Brill T, Stadler J. Pharmacokinetics and pharmacodynamics of vecuronium in rats with
systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine. Anesthesiology 1999; 91: 999-1005.
471. Narimatsu E, Nakayama Y, Sumita S, Iwasaki H, Fujimura N, Satoh K, et al. Sepsis attenuates the intensity of the neuromuscular blocking
effect of d-tubocurarine and the antagonistic actions of neostigmine and edrophonium accompanying depression of muscle contractility
of the diaphragm. Acta Anaesthesiol Scand 1999; 43: 196-201.
472. Soltész S, Mencke T, Mey C, Röhrig S, Diefenbach C, Molter GP. Influence of a continuous prednisolone medication on the time course
of neuromuscular block of atracurium in patients with chronic inflammatory bowel disease. Br J Anaesth 2008; 100: 798-802.
473. Blanloeil Y, Delaroche O, Tequi B, Gunst JP, Dixneuf B. [Prolonged apnoe after administration of succinylcholine during staphylococcal
57